Potential Nanotechnology-Based Therapeutics to Prevent Cancer Progression through TME Cell-Driven Populations
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with a high risk of metastasis and therapeutic resistance. These issues are closely linked to the tumour microenvironment (TME) surrounding the tumour tissue. The association between residing TME components with tum...
Main Authors: | Rafia Ali, Huimin Shao, Pegah Varamini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/1/112 |
Similar Items
-
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression
by: Enea Ferlizza, et al.
Published: (2023-05-01) -
Tumour Microenvironment-Immune Cell Interactions Influencing Breast Cancer Heterogeneity and Disease Progression
by: Keely Tan, et al.
Published: (2022-05-01) -
The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
by: Andras G. Lacko, et al.
Published: (2013-06-01) -
Expression of SOX10 in Triple-negative Breast Cancer.
by: Siyab Ahmad , Nadeem Zafar , Muhammad Owais Qurni , Muhammad Atif Khalil , Shabir Ahmad Orakzai , Wajahat Ahmad Khan
Published: (2023-09-01) -
Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy
by: Zeli Yin, et al.
Published: (2023-12-01)